These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24218731)

  • 1. [Early diagnosis of Alzheimer's disease].
    Seppälä T; Herukka SK; Remes AM
    Duodecim; 2013; 129(19):2003-10. PubMed ID: 24218731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of cerebrospinal fluid (CSF) biomarkers for Alzheimer's type dementia: diagnosis in mild cognitive impairment].
    Verhey FR; Visser PJ
    Ned Tijdschr Geneeskd; 2013; 157(11):A5596. PubMed ID: 23484512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid.
    Monge Argilés JA; Blanco Cantó MA; Leiva Salinas C; Flors L; Muñoz Ruiz C; Sánchez Payá J; Gasparini Berenguer R; Leiva Santana C
    Neurologia; 2014 Sep; 29(7):397-401. PubMed ID: 23969296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
    Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
    J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers.
    Ivanoiu A; Dricot L; Gilis N; Grandin C; Lhommel R; Quenon L; Hanseeuw B
    J Alzheimers Dis; 2015; 43(3):835-47. PubMed ID: 25114071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Molinuevo JL; Blennow K; Dubois B; Engelborghs S; Lewczuk P; Perret-Liaudet A; Teunissen CE; Parnetti L
    Alzheimers Dement; 2014 Nov; 10(6):808-17. PubMed ID: 25150736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.
    Blennow K; Zetterberg H
    Med Clin North Am; 2013 May; 97(3):369-76. PubMed ID: 23642576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New clinical criteria for the Alzheimer's disease spectrum.
    Petersen RC
    Minn Med; 2012 Jan; 95(1):42-5. PubMed ID: 22355912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.
    Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P
    J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's disease.
    Parnetti L; Chiasserini D
    Biomark Med; 2011 Aug; 5(4):479-84. PubMed ID: 21861669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in the diagnosis of Alzheimer's disease: are we ready?
    Sunderland T; Hampel H; Takeda M; Putnam KT; Cohen RM
    J Geriatr Psychiatry Neurol; 2006 Sep; 19(3):172-9. PubMed ID: 16880359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging for diagnosis of early Alzheimer's disease.
    Colliot O; Hamelin L; Sarazin M
    Rev Neurol (Paris); 2013 Oct; 169(10):724-8. PubMed ID: 24011982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of effective biomarkers for Alzheimer's disease: a review.
    Henry MS; Passmore AP; Todd S; McGuinness B; Craig D; Johnston JA
    Int J Geriatr Psychiatry; 2013 Apr; 28(4):331-40. PubMed ID: 22674539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the PredictAD software tool to predict progression in patients with mild cognitive impairment.
    Simonsen AH; Mattila J; Hejl AM; Frederiksen KS; Herukka SK; Hallikainen M; van Gils M; Lötjönen J; Soininen H; Waldemar G
    Dement Geriatr Cogn Disord; 2012; 34(5-6):344-50. PubMed ID: 23222123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How early can we predict Alzheimer's disease using computational anatomy?
    Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
    Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Markers of prodromal Alzheimer's disease].
    de Souza LC; Sarazin M; Uspenskaya O; Habert MO; Lamari F; Lehéricy S; Dubois B
    Rev Neurol (Paris); 2012 Nov; 168(11):815-24. PubMed ID: 22944619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
    Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
    Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.